CLINICAL MODELS OF CHEMOPREVENTION FOR CERVICAL CANCER
- 1 October 1998
- journal article
- review article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 12 (5) , 1115-1134
- https://doi.org/10.1016/s0889-8588(05)70043-5
Abstract
No abstract availableKeywords
This publication has 109 references indexed in Scilit:
- Cervical cancer mortality in Belgium, 1955–1989. A descriptive studyEuropean Journal Of Cancer, 1997
- Lack of association of HLA polymorphisms with human papillomavirus-related cervical cancerHuman Immunology, 1993
- Carotenoids and cancer: An update with emphasis on human intervention studiesEuropean Journal Of Cancer, 1993
- Tumour-infiltrating lymphocytes in cervical carcinomaEuropean Journal Of Cancer, 1992
- Definition of immunogenic determinants of the human papillomavirus type 16 nucleoprotein E7European Journal Of Cancer, 1992
- Genetic control of immune response and disease susceptibility by the HLA-DQ geneResearch in Immunology, 1991
- Immune suppression gene on HLA-Bw54-DR4-DRw53 haplotype controls nonresponsiveness in humans to hepatitis B surface antigen via CD8+ suppressor T cellsHuman Immunology, 1988
- Human Papillomavirus Type 16 and Early Cervical NeoplasiaNew England Journal of Medicine, 1984
- Risk factors for cervical cancerJournal of Chronic Diseases, 1982
- A study of cancer, parity and age at first pregnancyJournal of Chronic Diseases, 1980